Abstract
Retroviruses lacking oncogenes can induce tumours in animals, and the tumour cells are frequently found to contain proviral DNA inserted next to a proto-oncogene, which is thus placed under the regulatory control of the retroviral long terminal repeat (LTR). This altered regulation leads to overexpression of the protooncogene, which presumably contributes to the growth properties of the tumour cells1, fim-2 has been described as a retroviral integration site frequently and specifically involved in murine myeloblastic leukaemias induced in vivo or in vitro by the replication-competent Friend murine leukaemia virus (F-MuLV)2. Here we report that fim-2 spans the 5′-end of the murine proto-oncogene c-fms, known to code for a transmembrane glycoprotein with tyrosine kinase activity probably identical to the receptor of the haemopoietic growth factor, monocyte-macrophage colony-stimulating factor (M-CSF or CSF-1)3. Proviral integration in the fim-2 region results in a high expression of a normal sized c-fms messenger RNA. We also observe that some tumours have lost the fim-2/c-fms germ line allele. These results provide the first evidence for the presumed involvement of c-fms in myelomonocytic leukaemias.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nusse, R. Trends Genet. 2, 244–247 (1986).
Sola, B., Fichelson, S., Bordereaux, D., Tambourin, P. E. & Gisselbrecht, S. J. Virol. 60, 718–725 (1986).
Sherr, C. J. et al. Cell 41, 665–676 (1985).
Heard, J. M. et al. Molec. cell Biol. 4, 216–220 (1984).
Heard, J. M., Sola, B., Martial, M. A., Fichelson, S. & Gisselbrecht, S. Blood 68, 193–199 (1986).
Peters, G., Lee, A. E. & Dickson, C. Nature 320, 628–631 (1986).
Payne, G. S., Bishop, J. M. & Varmus, M. E. Nature 295, 209–214 (1982).
Shen-Ong, G. L. C., Morse, H. C., Potter, M. & Mushinski, J. F. Molec. cell Biol. 6, 380–392 (1986).
Weinstein, Y., Ihle, J. N., Laure, S. & Reddy, E. P. Proc. natn. Acad. Sci. U.S.A. 83, 5010–5014 (1986).
Mushinski, J. F., Potter, M., Bauer, S. R. & Reddy, E. P. Science 220, 795–798 (1983).
Müller, R. et al. Molec. cell Biol. 3, 1062–1069 (1983).
McDonough, S. K., Larsen, S., Brodey, R. S., Stock, N. D. & Hardy, W. D. Jr Cancer Res. 31, 953–956 (1971).
Wheeler, E. F. et al. J. Virol. 59, 224–233 (1986).
Sacca, R., Standley, E. R., Sherr, C. J. & Rettenmeier, C. W. Proc. natn. Acad. Sci. U.S.A. 83, 3331–3335 (1986).
Sarma, P. S., Sharar, A. & McDonough, S. Proc. Soc. exp. Biol. Med. 140, 1365–1368 (1972).
Groffen, J. et al. Nucleic Acids Res. 11, 6331–6339 (1983).
Le Beau, M. M. et al. Science 231, 984–987 (1986).
Pettenati, M. J. et al. Proc. natn. Acad. Sci. U.S.A. 84, 2970–2974 (1987).
Wisniewski, L. P. & Hirschhorn, K. Am. J. Hemat. 15, 206–210 (1983).
Huebner, K. et al. Science 230, 1282–1285 (1985).
Yang, Y-C. et al. Cell 47, 3–10 (1986).
Yarden, Y. C. et al. Nature 323, 226–232 (1986).
Nilsen, T. W. et al. Cell 41, 719–726 (1985).
Scherrer, K. in Fundamental Techniques in Virology (eds Habel, K. & Salzmann, N. P.) 413–432 (Academic, New York, 1969).
Donner, L., Fedele, L. A., Garon, C. F., Anderson, C. J. & Sherr, C. J. J. Virol. 41, 489–500 (1982).
Fort, P. et al. Nucleic Acids Res. 13, 1431–1442 (1985).
Roussel, M. F., Sherr, C. J., Barker, P. E. & Ruddle, F. H. J. Virol. 48, 770–773 (1983).
Coussens, L. et al. Nature 320, 277–280 (1986).
Eladari, M. E., Syed, S. H., Guilhot, S., d'Auriol, L. & Galibert, F. Biochem. biophys. Res. Commun. 140, 313–319 (1986).
Sanger, F. S., Nicklen, S. & Coulson, A. R. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).
Biggin, M. D., Gibson, T. S. & Hong, G. F. Proc. natn. Acad. Sci. U.S.A. 80, 3963–3965 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gisselbrecht, S., Fichelson, S., Sola, B. et al. Frequent c-fms activation by proviral insertion in mouse myeloblastic leukaemias. Nature 329, 259–261 (1987). https://doi.org/10.1038/329259a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/329259a0
This article is cited by
-
PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2
Nature Medicine (2010)
-
c-FMS chromatin structure and expression in normal and leukaemic myelopoiesis
Oncogene (2005)
-
Animal models of acute myelogenous leukaemia – development, application and future perspectives
Leukemia (2005)
-
Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease
Oncogene (2002)
-
Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies
Leukemia (2000)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
